Status
Conditions
Treatments
About
This study assesses whether patients with pancreatic cancer who undergo surgery experience improved outcomes following the implementation of a multidisciplinary care pathway, specifically an enhanced recovery after surgery (ERAS) program.
This pathway includes various interventions in the preoperative, intraoperative, and postoperative care of these patients, all aimed at enhancing their health status and postoperative results.
Full description
This prospective observational study is conducted by the same surgical team at two high-volume pancreatic cancer referral centers in Greece.
Patients undergoing elective pancreatic surgery are prospectively enrolled and managed according to a standardized ERAS protocol (ERAS group).
A control group, which received standard perioperative care before the implementation of ERAS, was retrospectively selected and matched based on demographic and clinical parameters.
The primary study endpoint is the length of hospital stay (LOS), while secondary endpoints include 30-day mortality and morbidity.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
170 participants in 2 patient groups
Loading...
Central trial contact
DESPOINA LIOTIRI, MD MSc PhD(c); ATHINA SAMARA, MD MSc PhD(c)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal